Basic Information
| RNALocate ID: | RLID:11001880 |
| RNA Symbol: | hsa-miR-126-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-126-3p |
| RNA ID: | miRBase:MIMAT0000445 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001817 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001818 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001819 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11001875 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11001876 | Exosome | Human umbilical vein endothelial cells|Serum | 29127370 |
| RLID:11001877 | Exosome | B cell line (Raji) | 21505438 |
| RLID:11001878 | Exosome | Breast milk | 22211110 |
| RLID:11001879 | Exosome | Brain tissue | 23382797 |
| RLID:11001881 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001882 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11001883 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001884 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001885 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000093 | Exosome | Blood|Endothelial cells|Epithelial cells|Mast cells | |
| RLID-D:11000373 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-126-3p | Diffuse large b cell lymphoma | MNDR-E-MI-07897 |
| MNDR | hsa-miR-126-3p | Splenic marginal zone lymphoma | MNDR-E-MI-07898 |
| MNDR | hsa-miR-126-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-07899 |
| MNDR | hsa-miR-126-3p | Oral squamous cell carcinoma | MNDR-E-MI-07900 |
| MNDR | hsa-miR-126-3p | Large cell neuroendocrine cancer | MNDR-E-MI-07901 |
| MNDR | hsa-miR-126-3p | Medulloblastoma | MNDR-E-MI-07902 |
| MNDR | hsa-miR-126-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-07903 |
| MNDR | hsa-miR-126-3p | Ovarian clear cell carcinoma | MNDR-E-MI-07904 |
| MNDR | hsa-miR-126-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-07905 |
| MNDR | hsa-miR-126-3p | Lymphoma | MNDR-E-MI-07906 |
| MNDR | hsa-miR-126-3p | Lymphoma non-hodgkin | MNDR-E-MI-07907 |
| MNDR | hsa-miR-126-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-07908 |
| MNDR | hsa-miR-126-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-07909 |
| MNDR | hsa-miR-126-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-07910 |
| MNDR | hsa-miR-126-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-07911 |
| MNDR | hsa-miR-126-3p | Her2-receptor positive breast cancer | MNDR-E-MI-07912 |
| MNDR | hsa-miR-126-3p | Triple negative breast cancer | MNDR-E-MI-07913 |
| MNDR | hsa-miR-126-3p | Acute promyelocytic leukemia | MNDR-E-MI-07914 |
| MNDR | hsa-miR-126-3p | Breast cancer luminal | MNDR-E-MI-07915 |
| MNDR | hsa-miR-126-3p | Anencephaly | MNDR-E-MI-07916 |
| MNDR | hsa-miR-126-3p | Niemann-pick disease type c | MNDR-E-MI-07917 |
| MNDR | hsa-miR-126-3p | Congenital myopathy | MNDR-E-MI-07918 |
| MNDR | hsa-miR-126-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-07919 |
| MNDR | hsa-miR-126-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-07920 |
| MNDR | hsa-miR-126-3p | Dermatomyositis | MNDR-E-MI-07921 |
| MNDR | hsa-miR-126-3p | Prostate cancer | MNDR-E-MI-07922 |
| MNDR | hsa-miR-126-3p | Gastric cancer | MNDR-E-MI-07923 |
| MNDR | hsa-miR-126-3p | Gastric lymphoma | MNDR-E-MI-07924 |
| MNDR | hsa-miR-126-3p | Alzheimer disease | MNDR-E-MI-07925 |
| MNDR | hsa-miR-126-3p | Intracranial aneurysm | MNDR-E-MI-07926 |
| MNDR | hsa-miR-126-3p | Sarcoma | MNDR-E-MI-07927 |
| MNDR | hsa-miR-126-3p | Dysautonomia familial | MNDR-E-MI-07928 |
| MNDR | hsa-miR-126-3p | Head and neck cancer | MNDR-E-MI-07929 |
| MNDR | hsa-miR-126-3p | Leukemia | MNDR-E-MI-07930 |
| MNDR | hsa-miR-126-3p | Friedreich ataxia | MNDR-E-MI-07931 |
| MNDR | hsa-miR-126-3p | Huntington disease | MNDR-E-MI-07932 |
| MNDR | hsa-miR-126-3p | Chorea | MNDR-E-MI-07933 |
| MNDR | hsa-miR-126-3p | Cardiovascular disease | MNDR-E-MI-07934 |
| MNDR | hsa-miR-126-3p | Moyamoya disease | MNDR-E-MI-07935 |
| MNDR | hsa-miR-126-3p | Lung cancer | MNDR-E-MI-07936 |
| MNDR | hsa-miR-126-3p | Biliary atresia | MNDR-E-MI-07937 |
| MNDR | hsa-miR-126-3p | Down syndrome | MNDR-E-MI-07938 |
| MNDR | hsa-miR-126-3p | Parkinson disease | MNDR-E-MI-07939 |
| MNDR | hsa-miR-126-3p | Niemann-pick disease | MNDR-E-MI-07940 |
| MNDR | hsa-miR-126-3p | Primary pulmonary hypertension | MNDR-E-MI-07941 |
| MNDR | hsa-miR-126-3p | Breast cancer | MNDR-E-MI-07942 |
| MNDR | hsa-miR-126-3p | Squamous cell carcinoma | MNDR-E-MI-07943 |
| MNDR | hsa-miR-126-3p | Thyroid cancer | MNDR-E-MI-07944 |
| MNDR | hsa-miR-126-3p | Pituitary neoplasms | MNDR-E-MI-07945 |
| MNDR | hsa-miR-126-3p | Pancreatic cancer | MNDR-E-MI-07946 |
| MNDR | hsa-miR-126-3p | Hepatitis C | MNDR-E-MI-07947 |
| MNDR | hsa-miR-126-3p | Melanoma | MNDR-E-MI-07948 |
| MNDR | hsa-miR-126-3p | Rectum adenocarcinoma | MNDR-E-MI-07949 |
| MNDR | hsa-miR-126-3p | Nephroblastoma | MNDR-E-MI-07950 |
| MNDR | hsa-miR-126-3p | Colon cancer | MNDR-E-MI-07951 |
| MNDR | hsa-miR-126-3p | Colon adenocarcinoma | MNDR-E-MI-07952 |
| MNDR | hsa-miR-126-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-07953 |
| MNDR | hsa-miR-126-3p | Familial ovarian cancer | MNDR-E-MI-07954 |
| MNDR | hsa-miR-126-3p | Acromegaly | MNDR-E-MI-07955 |
| MNDR | hsa-miR-126-3p | Prostate adenocarcinoma | MNDR-E-MI-07956 |
| MNDR | hsa-miR-126-3p | Kidney cancer | MNDR-E-MI-07957 |
| MNDR | hsa-miR-126-3p | Carcinoma ductal breast | MNDR-E-MI-07958 |
| MNDR | hsa-miR-126-3p | Invasive ductal carcinoma | MNDR-E-MI-07959 |
| MNDR | hsa-miR-126-3p | Glioblastoma | MNDR-E-MI-07960 |
| MNDR | hsa-miR-126-3p | Astrocytoma | MNDR-E-MI-07961 |
| MNDR | hsa-miR-126-3p | Glioma | MNDR-E-MI-07962 |
| MNDR | hsa-miR-126-3p | Oligodendroglioma | MNDR-E-MI-07963 |
| MNDR | hsa-miR-126-3p | Chordoma | MNDR-E-MI-07964 |
| MNDR | hsa-miR-126-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-07965 |
| MNDR | hsa-miR-126-3p | Osteosarcoma | MNDR-E-MI-07966 |
| MNDR | hsa-miR-126-3p | Liposarcoma | MNDR-E-MI-07967 |
| MNDR | hsa-miR-126-3p | Coronary artery disease | MNDR-E-MI-07968 |
| MNDR | hsa-miR-126-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-07969 |
| MNDR | hsa-miR-126-3p | Liver cancer | MNDR-E-MI-07970 |
| MNDR | hsa-miR-126-3p | Pituitary adenoma | MNDR-E-MI-07971 |
| MNDR | hsa-miR-126-3p | Lung squamous cell carcinoma | MNDR-E-MI-07972 |
| MNDR | hsa-miR-126-3p | Carcinoma lung non-small-cell | MNDR-E-MI-07973 |
| MNDR | hsa-miR-126-3p | Lung adenocarcinoma | MNDR-E-MI-07974 |
| MNDR | hsa-miR-126-3p | Thyroid carcinoma | MNDR-E-MI-07975 |
| MNDR | hsa-miR-126-3p | Tuberculosis | MNDR-E-MI-07976 |
| MNDR | hsa-miR-126-3p | Ovarian carcinoma | MNDR-E-MI-07977 |
| MNDR | hsa-miR-126-3p | Bladder urothelial carcinoma | MNDR-E-MI-07978 |
| MNDR | hsa-miR-126-3p | Pancreatic adenocarcinoma | MNDR-E-MI-07979 |
| MNDR | hsa-miR-126-3p | Liver disease | MNDR-E-MI-07980 |
| MNDR | hsa-miR-126-3p | Carcinoma renal cell | MNDR-E-MI-07981 |
| MNDR | hsa-miR-126-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-07982 |
| MNDR | hsa-miR-126-3p | Clear cell renal cell carcinoma | MNDR-E-MI-07983 |
| MNDR | hsa-miR-126-3p | Large cell carcinoma | MNDR-E-MI-07984 |
| MNDR | hsa-miR-126-3p | Biliary tract cancer | MNDR-E-MI-07985 |
| MNDR | hsa-miR-126-3p | Brain edema | MNDR-E-MI-07986 |
| MNDR | hsa-miR-126-3p | Cholangiocarcinoma | MNDR-E-MI-07987 |
| MNDR | hsa-miR-126-3p | Esophageal cancer | MNDR-E-MI-07988 |
| MNDR | hsa-miR-126-3p | Liver cirrhosis | MNDR-E-MI-07989 |
| MNDR | hsa-miR-126-3p | Small cell lung cancer | MNDR-E-MI-07990 |
| MNDR | hsa-miR-126-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-07991 |
| MNDR | hsa-miR-126-3p | Myocardial infarction | MNDR-E-MI-07992 |
| MNDR | hsa-miR-126-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-07993 |
| MNDR | hsa-miR-126-3p | Fibromyalgia | MNDR-E-MI-07994 |
| MNDR | hsa-miR-126-3p | Encephalomyelitis | MNDR-E-MI-07995 |
| MNDR | hsa-miR-126-3p | Pulmonary arterial hypertension | MNDR-E-MI-07996 |
| MNDR | hsa-miR-126-3p | Adenoma | MNDR-E-MI-07997 |
| MNDR | hsa-miR-126-3p | Breast invasive carcinoma | MNDR-E-MI-07998 |
| MNDR | hsa-miR-126-3p | Early hepatocellular carcinoma | MNDR-E-MI-07999 |
| MNDR | hsa-miR-126-3p | Familiar ovarian carcinoma | MNDR-E-MI-08000 |
| MNDR | hsa-miR-126-3p | B-cell lymphoma | MNDR-E-MI-08001 |
| MNDR | hsa-miR-126-3p | Rheumatoid arthritis | MNDR-E-MI-08002 |
| MNDR | hsa-miR-126-3p | T-cell leukemia | MNDR-E-MI-08003 |
| MNDR | hsa-miR-126-3p | Neuroblastoma | MNDR-E-MI-08004 |
| MNDR | hsa-miR-126-3p | Chronic kidney disease | MNDR-E-MI-08005 |
| MNDR | hsa-miR-126-3p | Chronic myeloid leukemia | MNDR-E-MI-08006 |
| MNDR | hsa-miR-126-3p | Hodgkin lymphoma | MNDR-E-MI-08007 |
| MNDR | hsa-miR-126-3p | Ulcerative colitis | MNDR-E-MI-08008 |
| MNDR | hsa-miR-126-3p | Burkitt lymphoma | MNDR-E-MI-08009 |
| MNDR | hsa-miR-126-3p | Tonsil cancer | MNDR-E-MI-08010 |
| MNDR | hsa-miR-126-3p | Neuromyelitis optica | MNDR-E-MI-08011 |
| MNDR | hsa-miR-126-3p | Acute myelocytic leukemia | MNDR-E-MI-08012 |
| MNDR | hsa-miR-126-3p | Colorectal cancer | MNDR-E-MI-08013 |
| MNDR | hsa-miR-126-3p | Nasopharynx carcinoma | MNDR-E-MI-08014 |
| MNDR | hsa-miR-126-3p | Diabetes mellitus | MNDR-E-MI-08015 |
| MNDR | hsa-miR-126-3p | Type 2 diabetes mellitus | MNDR-E-MI-08016 |
| MNDR | hsa-miR-126-3p | Multiple myeloma | MNDR-E-MI-08017 |
| MNDR | hsa-miR-126-3p | Ependymoma | MNDR-E-MI-08018 |
| MNDR | hsa-miR-126-3p | Nasopharyngeal cancer | MNDR-E-MI-08019 |
| MNDR | hsa-miR-126-3p | Prostatic neoplasms | MNDR-E-MI-08020 |
| MNDR | hsa-miR-126-3p | Sleep deprivation | MNDR-E-MI-08021 |
| MNDR | hsa-miR-126-3p | Aids dementia complex | MNDR-E-MI-08022 |
| MNDR | hsa-miR-126-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-08023 |
| MNDR | hsa-miR-126-3p | Gait ataxia | MNDR-E-MI-08024 |
| MNDR | hsa-miR-126-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-08025 |
| MNDR | hsa-miR-126-3p | Pancreatitis chronic | MNDR-E-MI-08026 |
| MNDR | hsa-miR-126-3p | Chronic pain | MNDR-E-MI-08027 |
| MNDR | hsa-miR-126-3p | Stroke lacunar | MNDR-E-MI-08028 |
| MNDR | hsa-miR-126-3p | Non-alcoholic fatty liver disease | MNDR-E-MI-08029 |
| MNDR | hsa-miR-126-3p | Breast cancer her3+ negative | MNDR-E-MI-08030 |
| MNDR | hsa-miR-126-3p | High grade dysplastic nodule | MNDR-E-MI-08031 |
| MNDR | hsa-miR-126-3p | Tubulovillous adenoma | MNDR-E-MI-08032 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ADAM9 | Homo sapiens | RR00041155 |
TOP